查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922397

日本照护现场诊断市场依产品类型、平台、处方模式、最终用户和地区划分，2026-2034年

Japan Point of Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本照护现场诊断市场规模达19亿美元。 IMARC集团预测，到2034年，该市场规模将达到40亿美元，2026年至2034年的复合年增长率（CAGR）为8.74%。癌症、糖尿病和心血管疾病等慢性病的增加，人们对社区诊所、药局和家庭环境的偏好转变，以及人口老化加剧，是推动市场成长的主要因素。

照护现场（POCD）是指在患者照护地点或附近进行的医学检测，能够快速提供结果，以便即时做出临床决策。这些检测操作简便，医护人员只需接受极少的训练即可上手。它们涵盖范围广泛，包括感染疾病的检测。即时诊断提高了医疗检测的可近性，尤其是在资源匮乏的地区。它们还有助于预防传染病在社区和医疗机构中的传播。即时诊断减少了患者多次就诊的次数，既方便又降低了医疗成本。它们有助于根据即时数据管理和调整治疗方案。即时诊断广泛应用于急诊护理，用于快速评估和诊断心臟病发作、败血症和呼吸窘迫等严重。

日本照护现场诊断（POCD）市场趋势：

癌症、糖尿病和心血管疾病等慢性病的日益增多，以及对定期监测和即时医疗回应需求的不断增长，是推动日本即时检测设备（POCD）需求的关键因素。此外，人口老化和住院率上升也促进了市场成长。快速的都市化、个人生活方式的改变以及肥胖和高血压等文明病风险的增加，也推动了国内市场的发展。即时检测设备能够对这些疾病进行及时监测和管理，从而增加了对即时检测设备的需求。人们越来越偏好选择社区诊所、药局和家庭就医，这也对市场产生了正面影响。此外，日本政府持续致力于医疗保健产业的现代化，为市场带来了良好的前景。政府已实施多项措施，并提供优惠的报销政策，以促进医疗服务中的技术整合。此外，日本强大的科技产业正积极推动小型化和自动化，确保即时检测设备达到最高的可靠性和易用性标准。同时，日本医疗服务提供者、诊断公司和研究机构之间日益紧密的合作也推动了市场前景的积极发展。这些伙伴关係促进了创新，并推动了针对特定疾病的即时检测（POC​​）解决方案的开发。此外，预防医学和疾病早期检测的日益普及也促进了市场成长。即时检测使个人能够定期监测自身健康状况，从而倡导积极主动的医疗保健方式，并减轻医疗机构的负担。日本民众对定期体检重要性的认识不断提高，也对市场产生了正面影响。

本报告解答的关键问题：

  • 日本照护现场诊断市场目前的表现如何？未来几年又将如何发展？
  • 新冠疫情对日本照护现场诊断市场产生了哪些影响？
  • 日本照护现场诊断市场依产品类型分類的组成是怎样的？
  • 日本照护现场诊断市场依平台分類的细分如何？
  • 日本照护现场诊断市场依处方模式分類的组成是怎样的？
  • 日本照护现场诊断市场依最终用户分類的组成是怎样的？
  • 请介绍日本照护现场诊断市场价值链的各个环节。
  • 日本照护现场诊断的关键驱动因素和挑战是什么？
  • 日本照护现场诊断市场的结构是怎么样的？主要企业有哪些？
  • 日本照护现场诊断市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章 日本照护现场诊断市场—简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本照护现场诊断市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

6. 日本照护现场诊断市场－依产品类型细分

  • 血糖值检测试剂盒
  • 心血管代谢监测套件
  • 怀孕与不孕症检测套组
  • 传染病检查试剂盒
  • 胆固醇试纸
  • 血液学检测套组
  • 其他的

7. 日本照护现场诊断市场－按平台细分

  • 横向流动化验
  • 油尺
  • 微流体技术
  • 分子诊断
  • 免疫检测

8. 日本照护现场诊断市场－依处方模式细分

  • 处方笺测试
  • 市售测试

第九章 日本照护现场诊断市场－依最终用户细分

  • 专业诊断中心
  • 居家医疗
  • 研究所
  • 其他的

第十章 日本照护现场诊断市场－按地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十一章：日本照护现场诊断市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十二章主要企业概况

第十三章：日本照护现场诊断市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十四章附录

简介目录
Product Code: SR112026A19664

Japan point of care diagnostics market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.74% during 2026-2034. The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, shifting preferences towards community clinics, pharmacies, and home settings, and the expanding aging population represent some of the key factors driving the market.

Point of care diagnostics (POCD) refers to medical tests conducted at or near the site of patient care, providing rapid results for immediate clinical decisions. It is user-friendly, requiring minimal training for healthcare professionals and encompasses a broad spectrum of tests for infectious diseases, chronic conditions, pregnancy, and various biomarkers. It enhances accessibility to medical testing, especially in resource-limited settings. It aids in preventing the spread of contagious diseases within communities or healthcare facilities. It reduces the need for multiple clinical visits, offering convenience and potentially lowering healthcare costs. It assists in managing and adjusting treatment plans based on real-time data. It is widely used in emergency medicine to quickly assess and diagnose critical conditions, such as cardiac events, sepsis, or respiratory distress.

Japan Point of Care Diagnostics Market Trends:

The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, coupled with this rising need for regular monitoring and immediate medical attention, represents one of the primary factors driving the demand for POCD in Japan. Additionally, the expanding aging population and the increasing hospitalization rates are facilitating the market growth. Along with this, rapid urbanization, changing lifestyles of individuals, and the rising risk of lifestyle-related diseases, such as obesity and hypertension, are driving the market in the country. POCD facilitates the timely monitoring and management of these conditions, leading to greater demand for POC testing devices. Apart from this, shifting preferences towards community clinics, pharmacies, and home settings are influencing the market positively. Moreover, governing authorities of the country are continuously focusing on the modernization of the healthcare sector, which is offering a favorable market outlook. They are implementing several initiatives and offering favorable reimbursement rates that encourage technological integration in healthcare services. Furthermore, the robust technology sector of Japan is actively engaged in miniaturization and automation, ensuring that POCDs meet the highest standards of reliability and usability. Along with this, rising collaborations between healthcare providers, diagnostic companies, and research institutions in Japan are creating a positive outlook for the market. These partnerships foster innovation and enable the development of tailored POC solutions for specific medical conditions. In addition, the rising shift towards preventive healthcare and early disease detection is bolstering the market growth. POC diagnostics empower individuals to monitor their health regularly, fostering a proactive approach to healthcare and reducing the burden on healthcare facilities. The growing awareness among the Japanese population about the importance of regular health check-ups is influencing the market positively.

Japan Point of Care Diagnostics Market Segmentation:

Product Type Insights:

  • Blood-Glucose Monitoring Kit
  • Cardio-Metabolic Monitoring Kit
  • Pregnancy and Fertility Testing Kit
  • Infectious Disease Testing Kit
  • Cholesterol Test Strip
  • Hematology Testing Kit
  • Others

Platform Insights:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Prescription Mode Insights:

  • Prescription-Based Testing
  • OTC Testing

End User Insights:

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan point of care diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan point of care diagnostics market?
  • What is the breakup of the Japan point of care diagnostics market on the basis of product type?
  • What is the breakup of the Japan point of care diagnostics market on the basis of platform?
  • What is the breakup of the Japan point of care diagnostics market on the basis of prescription mode?
  • What is the breakup of the Japan point of care diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan point of care diagnostics market?
  • What are the key driving factors and challenges in the Japan point of care diagnostics?
  • What is the structure of the Japan point of care diagnostics market and who are the key players?
  • What is the degree of competition in the Japan point of care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Point of Care Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Point of Care Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Point of Care Diagnostics Market - Breakup by Product Type

  • 6.1 Blood-Glucose Monitoring Kit
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Cardio-Metabolic Monitoring Kit
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Pregnancy and Fertility Testing Kit
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Infectious Disease Testing Kit
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Cholesterol Test Strip
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Hematology Testing Kit
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2020-2025)
    • 6.7.2 Market Forecast (2026-2034)

7 Japan Point of Care Diagnostics Market - Breakup by Platform

  • 7.1 Lateral Flow Assays
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Dipsticks
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Microfluidics
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Molecular Diagnostics
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Immunoassays
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)

8 Japan Point of Care Diagnostics Market - Breakup by Prescription Mode

  • 8.1 Prescription-Based Testing
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 OTC Testing
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Point of Care Diagnostics Market - Breakup by End User

  • 9.1 Professional Diagnostic Centers
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Home Care
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Research Laboratories
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2020-2025)
    • 9.4.2 Market Forecast (2026-2034)

10 Japan Point of Care Diagnostics Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product Type
    • 10.1.4 Market Breakup by Platform
    • 10.1.5 Market Breakup by Prescription Mode
    • 10.1.6 Market Breakup by End User
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product Type
    • 10.2.4 Market Breakup by Platform
    • 10.2.5 Market Breakup by Prescription Mode
    • 10.2.6 Market Breakup by End User
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product Type
    • 10.3.4 Market Breakup by Platform
    • 10.3.5 Market Breakup by Prescription Mode
    • 10.3.6 Market Breakup by End User
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product Type
    • 10.4.4 Market Breakup by Platform
    • 10.4.5 Market Breakup by Prescription Mode
    • 10.4.6 Market Breakup by End User
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product Type
    • 10.5.4 Market Breakup by Platform
    • 10.5.5 Market Breakup by Prescription Mode
    • 10.5.6 Market Breakup by End User
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product Type
    • 10.6.4 Market Breakup by Platform
    • 10.6.5 Market Breakup by Prescription Mode
    • 10.6.6 Market Breakup by End User
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product Type
    • 10.7.4 Market Breakup by Platform
    • 10.7.5 Market Breakup by Prescription Mode
    • 10.7.6 Market Breakup by End User
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product Type
    • 10.8.4 Market Breakup by Platform
    • 10.8.5 Market Breakup by Prescription Mode
    • 10.8.6 Market Breakup by End User
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Point of Care Diagnostics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Services Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Services Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Services Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Services Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Services Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Point of Care Diagnostics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix